Search

1. Rx watchdog report: drug prices continue to climb despite lack of growth in general inflation rate

Publication:

Washington, D.C. : AARP Public Policy Institute, c2009

Subject(s):

Drug Costs -- statistics & numerical data
Drug Costs -- trends
Drug Industry -- economics
Inflation, Economic -- statistics & numerical data
Inflation, Economic -- trends
Prescription Drugs -- economics

2. Potential misclassifications reported by drug manufacturers may have led to $1 billion in lost Medicaid rebates

Publication:

[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, December 2017

Subject(s):

Drug Costs
Drug Industry -- economics
Medicaid -- economics
Pharmaceutical Preparations -- classification
Pharmaceutical Preparations -- economics
United States
United States. Department of Health and Human Services
Centers for Medicare & Medicaid Services (U.S.)

3. Research and development in the pharmaceutical industry

Author(s):

Austin, David, author
Hayford, Tamara, author

Publication:

[Washington, DC] : Congressional Budget Office, April 2021

Subject(s):

Drug Development -- economics
Drug Industry -- economics
Research -- economics
Economics, Pharmaceutical
United States

4. Trends in manufacturer prices of generic prescription drugs used by older Americans-first quarter 2004 update

Author(s):

Gross, D. (David)

Publication:

Washington, D.C. : AARP Public Policy Institute, [2004]

Subject(s):

Drug Industry -- economics
Drug Industry -- trends
Drug Prescriptions -- economics
Drugs, Generic -- economics
United States

5. Trends in manufacturer prices of brand name prescription drugs used by older Americans-second and third quarter 2004 update

Author(s):

Gross, D. (David)

Publication:

[Washington, D.C.] : AARP Public Policy Institute, [2004]

Subject(s):

Drug Industry -- economics
Drug Industry -- trends
Drug Prescriptions -- economics
United States

6. Drug industry: profits, research and development spending, and merger and acquisition deals : report to Congressional requesters

Publication:

Washington, DC : United States Government Accountability Office, November 2017

Subject(s):

Drug Costs
Drug Industry -- economics
Economics, Pharmaceutical -- trends
Pharmaceutical Research -- economics
Pharmaceutical Research -- trends
United States
National Institutes of Health (U.S.)

7. Competition in prescription drug markets, 2017-2022

Author(s):

Parasrampuria, Sonal, author
Murphy, Stephen J. (Stephen James), author

Publication:

Washington, D.C. : Office of the Assistant Secretary for Planning and Evaluation (ASPE), U.S. Department of Health and Human Services, December 2023

Subject(s):

Drug Costs -- statistics & numerical data
Drug Costs -- trends
Economic Competition
Drug Industry -- economics
Drug Industry -- trends
Prescription Drugs -- economics
United States

8. Congreso Internacional de Derecho y Economia Farmaceutica

Author(s):

Congreso Internacional de Derecho y Economia Farmaceutica (1990 : Granada, Spain)

Publication:

[Grenada, Spain : Cátedra de Historia de la Farmacia y Legislación Farmacéutica, Facultad de Farmacia, Campus Universitario de la Cartuja, 1990]

Subject(s):

Legislation, Pharmacy
Drug Industry -- economics
Drug Industry -- legislation & jurisprudence
Economics, Pharmaceutical

9. Fundamentals of the prescription drug market

Author(s):

Peters, Christie Provost.

Publication:

Washington, D.C. : National Health Policy Forum, [2004]

Subject(s):

Drug Industry -- economics
United States

10. The vaccine industry: does it need a shot in the arm?

Publication:

Washington, D.C. : National Health Policy Forum, [2006]

Subject(s):

Drug Industry -- economics
Vaccines -- supply & distribution
United States